Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Journal of Pharmaceutical Sciences
|
June 14, 2024
Insight Into the Degradation Pathways of an AAV9
Antonela Rodriguez, Supriya Jalimarada-Shivakumar, Ali Banazadeh, et al.
Annals of Surgical Oncology
|
July 27, 2007
Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice
Todd W Bauer, Fan Fan, Wenbiao Liu, et al.
Cancer Research
|
August 28, 2003
An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation
Erin K Maloney, Jennifer L McLaughlin, Nancy E Dagdigian, et al.
Pharmaceutical Research
|
February 20, 2025
In vitro Stability Study of a Panel of Commercial Antibodies at Physiological pH and Temperature as a Guide to Screen Biologic Candidate Molecules for the Potential Risk of In vivo Asparagine Deamidation and Activity Loss
Richa Garg, Sean McCarthy, Alayna George Thompson, et al.
Molecular Pharmaceutics
|
October 15, 2019
Optimizing Lysosomal Activation of Antibody-Drug Conjugates (ADCs) by Incorporation of Novel Cleavable Dipeptide Linkers
Paulin L Salomon, Emily E Reid, Katie E Archer, et al.
Molecular Cancer Therapeutics
|
April 24, 2015
IMGN853, a Folate Receptor-α (FRα)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors
Olga Ab, Kathleen R Whiteman, Laura M Bartle, et al.
Journal of Medicinal Chemistry
|
April 27, 2011
Synthesis and evaluation of hydrophilic linkers for antibody-maytansinoid conjugates
Robert Y Zhao, Sharon D Wilhelm, Charlene Audette, et al.
Bioconjugate Chemistry
|
March 24, 2011
Disulfide-linked antibody-maytansinoid conjugates: optimization of in vivo activity by varying the steric hindrance at carbon atoms adjacent to the disulfide linkage
Brenda A Kellogg, Lisa Garrett, Yelena Kovtun, et al.
ACS Medicinal Chemistry Letters
|
August 16, 2019
Synthesis of Highly Potent N-10 Amino-Linked DNA-Alkylating Indolinobenzodiazepine Antibody-Drug Conjugates (ADCs)
Katie E Archer, Emily E Reid, Manami Shizuka, et al.
Molecular Cancer Therapeutics
|
May 25, 2016
A New Class of Antibody-Drug Conjugates with Potent DNA Alkylating Activity
Michael L Miller, Nathan E Fishkin, Wei Li, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Journal of Pharmaceutical Sciences
|
June 14, 2024
Insight Into the Degradation Pathways of an AAV9
Antonela Rodriguez, Supriya Jalimarada-Shivakumar, Ali Banazadeh, et al.
Annals of Surgical Oncology
|
July 27, 2007
Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice
Todd W Bauer, Fan Fan, Wenbiao Liu, et al.
Cancer Research
|
August 28, 2003
An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation
Erin K Maloney, Jennifer L McLaughlin, Nancy E Dagdigian, et al.
Pharmaceutical Research
|
February 20, 2025
In vitro Stability Study of a Panel of Commercial Antibodies at Physiological pH and Temperature as a Guide to Screen Biologic Candidate Molecules for the Potential Risk of In vivo Asparagine Deamidation and Activity Loss
Richa Garg, Sean McCarthy, Alayna George Thompson, et al.
Molecular Pharmaceutics
|
October 15, 2019
Optimizing Lysosomal Activation of Antibody-Drug Conjugates (ADCs) by Incorporation of Novel Cleavable Dipeptide Linkers
Paulin L Salomon, Emily E Reid, Katie E Archer, et al.
Molecular Cancer Therapeutics
|
April 24, 2015
IMGN853, a Folate Receptor-α (FRα)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors
Olga Ab, Kathleen R Whiteman, Laura M Bartle, et al.
Journal of Medicinal Chemistry
|
April 27, 2011
Synthesis and evaluation of hydrophilic linkers for antibody-maytansinoid conjugates
Robert Y Zhao, Sharon D Wilhelm, Charlene Audette, et al.
Bioconjugate Chemistry
|
March 24, 2011
Disulfide-linked antibody-maytansinoid conjugates: optimization of in vivo activity by varying the steric hindrance at carbon atoms adjacent to the disulfide linkage
Brenda A Kellogg, Lisa Garrett, Yelena Kovtun, et al.
ACS Medicinal Chemistry Letters
|
August 16, 2019
Synthesis of Highly Potent N-10 Amino-Linked DNA-Alkylating Indolinobenzodiazepine Antibody-Drug Conjugates (ADCs)
Katie E Archer, Emily E Reid, Manami Shizuka, et al.
Molecular Cancer Therapeutics
|
May 25, 2016
A New Class of Antibody-Drug Conjugates with Potent DNA Alkylating Activity
Michael L Miller, Nathan E Fishkin, Wei Li, et al.
Page
of 3